You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 5,635,172


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,635,172
Title: Sustained release comfort formulation for glaucoma therapy
Abstract:Disclosed are nonstinging, sustained release ophthalmic formulations to control intraocular pressure in antiglaucoma therapy comprising a basic active, a cation exchange resin, and, inter alia, an acidic, mucomimetic polymer. Also disclosed are methods of treatment comprising administering such formulations topically to the eye when indicated for control and lowering of intraocular pressure.
Inventor(s): Jani; Rajni (Fort Worth, TX), Harris; Robert G. (Fort Worth, TX)
Assignee: Alcon Laboratories, Inc. (Fort Worth, TX)
Application Number:08/396,284
Patent Claim Types:
see list of patent claims
Composition; Compound; Use;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 5,635,172: A Comprehensive Analysis

Introduction

United States Patent 5,635,172, like any other patent, is a complex document that outlines the invention, its claims, and the legal protections afforded to the inventor. To delve into the specifics of this patent, we need to examine several key aspects, including the invention itself, the claims made, the patent landscape, and relevant legal and procedural considerations.

The Invention

What is the Patent About?

To analyze the patent, we first need to understand what the invention is. The title and abstract of the patent provide a preliminary overview. For example, if the patent is related to a technological innovation, it would describe the problem it solves, the novel features, and how it operates.

Determining Inventorship

Inventorship is a critical aspect of any patent application. According to US patent law, whoever "invents" the patentable subject matter is entitled to the patent. This involves identifying each person who conceived the idea or ideas of the patent claims. Conception is defined as the formation in the mind of the inventor of a definite and permanent idea of the complete and operative invention[4].

The Claims

Types of Claims

Patent claims are the heart of a patent application, defining the scope of the invention and what is protected. There are different types of claims, including independent claims and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit an independent claim.

Claim Construction

Claim construction is the process of interpreting the meaning of the claims. This is crucial because the scope of the claims determines the extent of the patent's protection. The claims must be clear and definite to avoid ambiguity and potential litigation[4].

Patent Landscape

Technology Field

The patent landscape includes the broader technological field in which the invention resides. For instance, the USPTO categorizes patents into various technology fields such as Chemical, Drugs and Medical, Electrical and Electronics, Computers and Communications, and Mechanical. Understanding the technology field helps in assessing the novelty and non-obviousness of the invention[1].

Prior Art and Novelty

Prior art refers to existing knowledge and inventions in the field that predate the filing of the patent application. The invention must be novel and non-obvious over the prior art to be patentable. A thorough search of prior art is essential to ensure that the invention meets these criteria.

Legal Considerations

Obviousness-Type Double Patenting

Obviousness-type double patenting (ODP) is a doctrine that prevents patentees from obtaining a second patent on a patentably indistinct invention to effectively extend the life of a first patent. Recent Federal Circuit decisions, such as in Allergan USA, Inc. v. MSN Laboratories Private Ltd., have clarified that a first-filed, first-issued, later-expiring patent claim cannot be invalidated for ODP by a later-filed, later-issued, earlier-expiring reference patent claim having a common priority date[2].

Patent Term Adjustments

Patent term adjustments (PTA) can affect the expiration dates of patents, which is relevant when evaluating ODP. The Federal Circuit has held that when analyzing ODP, the relevant expiration date is the expiration date, including any PTA[2].

Procedural Considerations

Filing and Examination Process

The filing and examination process involves several steps, including the initial filing, first-action allowance, and potential continuation applications. The USPTO tracks these applications and their outcomes, providing data on allowance rates and other metrics. For example, the first-action allowance rate, progenitor allowance rate, and family allowance rate are key metrics in understanding the likelihood of a patent being granted[1].

Continuation Applications

Continuation applications are a common strategy in patent prosecution, allowing applicants to pursue additional claims or modifications to the original invention. These applications can emerge from progenitor applications and can significantly impact the overall patent landscape[1].

Economic and Statistical Analysis

Patent Claims Research Dataset

The USPTO's Patent Claims Research Dataset provides detailed information on claims from US patents granted between 1976 and 2014 and US patent applications published between 2001 and 2014. This dataset can be used to analyze trends and metrics related to patent claims, including claim-level statistics and document-level statistics[3].

Allowance Rates

Analyzing allowance rates can provide insights into the likelihood of a patent being granted. For instance, the progenitor allowance rate and family allowance rate can indicate the success rate of patent applications in different technology fields[1].

Potential for Litigation

Small Claims Patent Court

The concept of a small claims patent court has been explored to address the high costs and complexity of patent litigation. Studies by the Administrative Conference of the United States (ACUS) have considered the feasibility and structure of such a court, which could impact how patent disputes related to inventions like those in US Patent 5,635,172 are resolved[5].

Key Takeaways

  • Inventorship: Determining who conceived the invention is crucial for patent validity.
  • Claims Construction: Clear and definite claims are essential for defining the scope of protection.
  • Patent Landscape: Understanding the technology field and prior art is vital for assessing novelty and non-obviousness.
  • Legal Considerations: ODP and PTA can significantly impact the validity and term of a patent.
  • Procedural Considerations: The filing and examination process, including continuation applications, can affect the outcome of a patent application.
  • Economic Analysis: Using datasets like the Patent Claims Research Dataset can provide valuable insights into patent trends and metrics.

FAQs

What is the significance of claim construction in a patent?

Claim construction is critical because it determines the scope of the invention and what is protected by the patent. Clear and definite claims are essential to avoid ambiguity and potential litigation.

How does obviousness-type double patenting affect patent validity?

ODP prevents patentees from obtaining a second patent on a patentably indistinct invention to extend the life of a first patent. Recent decisions have clarified that first-filed, first-issued patents cannot be invalidated by later-filed, later-issued patents with a common priority date.

What is the role of continuation applications in patent prosecution?

Continuation applications allow applicants to pursue additional claims or modifications to the original invention, emerging from progenitor applications. This can significantly impact the overall patent landscape and the likelihood of a patent being granted.

How can the Patent Claims Research Dataset be used?

The dataset provides detailed information on claims from US patents and applications, allowing for the analysis of trends and metrics related to patent claims, including claim-level and document-level statistics.

What is the potential impact of a small claims patent court on patent litigation?

A small claims patent court could address the high costs and complexity of patent litigation, providing a more accessible and efficient way to resolve patent disputes.

Sources

  1. Carley, M., & Hegde, D. (n.d.). What Is the Probability of Receiving a US Patent?. Retrieved from https://yjolt.org/sites/default/files/carley_hegde_marco-what_is_the_probability_of_receiving_a_us_patent_0.pdf
  2. Whitecase. (2024, August 15). Federal Circuit Limits the Application of Obviousness-Type Double Patenting for Patents in the Same Family. Retrieved from https://www.whitecase.com/insight-alert/federal-circuit-limits-application-obviousness-type-double-patenting-patents-same
  3. USPTO. (2017, August 28). Patent Claims Research Dataset. Retrieved from https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. Oregon State University. (n.d.). Determining Inventorship for US Patent Applications. Retrieved from https://agsci.oregonstate.edu/sites/agsci/files/main/research/vrc_release_inventorship-gattari.pdf
  5. ACUS. (n.d.). U.S. Patent Small Claims Court. Retrieved from https://www.acus.gov/research-projects/us-patent-small-claims-court

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 5,635,172

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.